Stanislav Naryzhny | Proteomics | Best Researcher Award

Prof . Stanislav Naryzhny | Proteomics | Best Researcher Award

Leading Scientist at PNPI, Russia

Dr. Stanislav Naryzhny is a distinguished protein biochemist with over four decades of dedicated research in biochemistry, proteomics, and molecular biology. He holds both Ph.D. and D.Sc. degrees in Biology, specializing in biochemistry. As a Leading Scientist at the St.-Petersburg Nuclear Physics Institute and an Adjunct Professor at Laurentian University, Canada, Dr. Naryzhny has significantly contributed to understanding DNA replication, proteoform diversity, and tumor marker identification. He is renowned for his technical expertise in mass spectrometry, protein purification, and proteome mapping, with an extensive record of high-impact publications. His work bridges fundamental research with practical applications, evident in his innovations and patents related to DNA and protein fractionation. A recipient of numerous research grants and institutional awards, Dr. Naryzhny remains an influential figure in biochemical research. His exceptional communication skills, collaborative approach, and leadership in international academic settings make him a highly suitable candidate for the Best Researcher Award.

Professional Profile 

Education🎓

Dr. Stanislav Naryzhny’s academic journey reflects a deep-rooted commitment to the life sciences. He earned his Master’s degree in Biophysics from Tbilisi State University in Georgia in 1974, establishing a strong foundation in molecular and structural biology. He later pursued his Ph.D. in Biology, specializing in Biochemistry and Radiobiology, awarded by the Russian Academy of Sciences in 1984. Building on his doctoral work, he attained a Doctor of Science (D.Sc.) degree in Biology with a focus on Biochemistry, further solidifying his expertise in protein structure-function relationships and DNA repair mechanisms. In addition to his formal academic qualifications, Dr. Naryzhny completed postdoctoral training at the Northeastern Ontario Regional Cancer Centre in Canada, where he deepened his research on cell and molecular biology, particularly in DNA replication and cell-cycle proteomics. He also holds certifications in MALDI mass spectrometry operation and health and safety training, reflecting his multidisciplinary capabilities and continuous professional development.

Professional Experience📝

Dr. Naryzhny brings a rich professional background spanning over 45 years, with significant contributions to both Russian and Canadian research institutions. He began his career in the 1970s at the St.-Petersburg Nuclear Physics Institute (PNPI), Russian Academy of Sciences, where he steadily advanced through research roles, eventually becoming a Leading Scientist in 2010. His research has primarily focused on DNA repair, replication mechanisms, and proteomics. From 1999 to 2009, he worked in Canada as a Postdoctoral Researcher and later Associate Scientist at the Northeastern Ontario Regional Cancer Centre and Sudbury Regional Hospital, focusing on cell-cycle regulation and proteome analysis. Since 2008, he has served as an Adjunct Professor in the Department of Chemistry and Biochemistry at Laurentian University, engaging in academic collaboration and student mentorship. His experience includes managing research teams, conducting grant-funded projects, and developing new methodologies in protein biochemistry, establishing him as a leader in his field.

Research Interest🔎

Dr. Naryzhny’s research interests lie at the intersection of protein biochemistry, cellular proteomics, and DNA replication machinery. His primary focus is on understanding the molecular structure and functional diversity of proteoforms, especially in the context of cancer diagnostics. He has conducted pioneering work on the role of PCNA (proliferating cell nuclear antigen) in coordinating multiple cellular functions and its implications in tumorigenesis. His studies extend to the structural and dynamic organization of DNA replication machinery, particularly in mammalian cells. He has also explored the development and application of 2D electrophoresis-based proteomic profiling techniques, which have implications in identifying novel tumor biomarkers such as haptoglobin proteoforms in glioblastoma. His work bridges biophysical analysis, bioinformatics, and translational science, with an emphasis on improving the understanding of the cell cycle and protein expression under both normal and pathological conditions. His contributions continue to shape the field of proteome-based disease diagnosis and therapy.

Award and Honor🏆

Dr. Naryzhny has received numerous prestigious awards and honors in recognition of his outstanding scientific contributions. Notably, he has been a recipient of multiple grants from the Russian Science Foundation, the Russian Fund of Fundamental Investigations, and the International Science Foundation, highlighting his sustained research excellence. His work has been supported by Canadian institutions such as the NCIC, and he has received internal awards from the St.-Petersburg Nuclear Physics Institute across several years. He was also recognized at the Keystone Symposium and received honors for poster presentations at international conferences. His early contributions were celebrated with PNPI awards dating back to the 1970s and 1980s. These accolades underscore his global recognition and influence in the fields of biochemistry and molecular biology. Dr. Naryzhny’s consistent ability to secure competitive research funding and academic distinction showcases his impact and dedication, making him a deserving recipient of accolades such as the Best Researcher Award.

Research Skill🔬

Dr. Stanislav Naryzhny possesses an expansive and versatile skill set that underpins his innovative biochemical research. He is an expert in mass spectrometry, 2D electrophoresis, protein expression and purification, Western and Far-Western blotting, and HPLC techniques, all essential for high-level proteomic studies. His proficiency in cell biology includes tissue culture, transfection, confocal microscopy, FACS, and immunocytochemistry. In immunology, he has developed polyclonal antibodies and has extensive experience in laboratory animal handling. On the computational front, he is skilled in using various bioinformatics tools for proteomics and genomics, along with molecular modeling and database analysis. His knowledge extends to software such as GraphPad Prism, Swiss-PdbViewer, and Phoretix 2D. Beyond the lab, Dr. Naryzhny also has skills in scientific visualization and poster design. This diverse technical repertoire supports his groundbreaking research and positions him as a highly skilled and adaptable scientist in the rapidly evolving field of molecular and cellular biology.

Conclusion💡

Dr. Stanislav Naryzhny is highly suitable for the Best Researcher Award, particularly due to his:

  • Long-standing contributions to biochemistry and proteomics

  • Consistent publication in high-quality journals

  • Leadership in both Russian and Canadian scientific communities

  • Technological innovations and applied research

While the profile could be enhanced with recent citation metrics and global leadership roles, his lifetime achievement, ongoing productivity, and technical depth make him a strong and deserving candidate for this recognition.

Publications Top Noted✍

  • Title: Proliferating cell nuclear antigen: a proteomics view
    Authors: SN Naryzhny
    Year: 2008
    Citations: 317

  • Title: The post-translational modifications of proliferating cell nuclear antigen: acetylation, not phosphorylation, plays an important role in the regulation of its function
    Authors: SN Naryzhny, H Lee
    Year: 2004
    Citations: 155

  • Title: Proliferating cell nuclear antigen in the cytoplasm interacts with components of glycolysis and cancer
    Authors: SN Naryzhny, H Lee
    Year: 2010
    Citations: 115

  • Title: Proliferating cell nuclear antigen (PCNA) may function as a double homotrimer complex in the mammalian cell
    Authors: SN Naryzhny, H Zhao, H Lee
    Year: 2005
    Citations: 94

  • Title: The immortalizing and transforming ability of two common human papillomavirus 16 E6 variants with different prevalences in cervical cancer
    Authors: C Richard, C Lanner, SN Naryzhny, L Sherman, H Lee, PF Lambert, …
    Year: 2010
    Citations: 92

  • Title: Chromosome 18 transcriptome profiling and targeted proteome mapping in depleted plasma, liver tissue and HepG2 cells
    Authors: VG Zgoda, AT Kopylov, OV Tikhonova, AA Moisa, NV Pyndyk, …
    Year: 2013
    Citations: 79

  • Title: Characterization of proliferating cell nuclear antigen (PCNA) isoforms in normal and cancer cells: there is no cancer-associated form of PCNA
    Authors: SN Naryzhny, H Lee
    Year: 2007
    Citations: 75

  • Title: Proteome of glioblastoma-derived exosomes as a source of biomarkers
    Authors: S Naryzhny, A Volnitskiy, A Kopylov, E Zorina, R Kamyshinsky, …
    Year: 2020
    Citations: 64

  • Title: Chromosome-centric approach to overcoming bottlenecks in the Human Proteome Project
    Authors: A Archakov, V Zgoda, A Kopylov, S Naryzhny, A Chernobrovkin, …
    Year: 2012
    Citations: 56

  • Title: Plasma exosomes stimulate breast cancer metastasis through surface interactions and activation of FAK signaling
    Authors: T Shtam, S Naryzhny, R Samsonov, D Karasik, I Mizgirev, A Kopylov, …
    Year: 2019
    Citations: 52

  • Title: Blue Dry Western: Simple, economic, informative, and fast way of immunodetection
    Authors: SN Naryzhny
    Year: 2009
    Citations: 52

  • Title: Protein profiles of the Chinese hamster ovary cells in the resting and proliferating stages
    Authors: SN Naryzhny, H Lee
    Year: 2001
    Citations: 51

  • Title: Virtual-experimental 2DE approach in chromosome-centric human proteome project
    Authors: SN Naryzhny, MA Maynskova, VG Zgoda, NL Ronzhina, OA Kleyst, …
    Year: 2016
    Citations: 41

  • Title: Combination of virtual and experimental 2DE together with ESI LC‐MS/MS gives a clearer view about proteomes of human cells and plasma
    Authors: SN Naryzhny, VG Zgoda, MA Maynskova, SE Novikova, NL Ronzhina, …
    Year: 2016
    Citations: 40

  • Title: Characterization of the human proliferating cell nuclear antigen physico-chemical properties: aspects of double trimer stability
    Authors: SN Naryzhny, LV DeSouza, KWM Siu, H Lee
    Year: 2006
    Citations: 40

  • Title: Haptoglobin as a biomarker
    Authors: SN Naryzhny, OK Legina
    Year: 2021
    Citations: 39

Pintu Prajapati | Pharmaceutical Analysis | Best Researcher Award

🌟Dr. Pintu Prajapati, Pharmaceutical Analysis, Best Researcher Award 🏆

  Doctorate at Maliba Pharmacy College, India

Dr. Pintu B. Prajapati is a dedicated academic and researcher with a strong focus on pharmaceutical analysis and quality assurance. With extensive experience in teaching, research, and publication, he has made significant contributions to the field, garnering recognition for his work through awards and honors.

Author Metrics:

Dr. Prajapati’s research output is reflected in his author metrics, showcasing a significant number of publications in high-impact journals. His work has garnered attention within the scientific community, evident from his citation count and the impact factors of the journals in which he publishes.

Orcid Profile

Scopus Profile

Dr. Pintu B. Prajapati is affiliated with Maliba Pharmacy College in Tarsadi, India. He has a Scopus Author Identifier and has been cited 409 times across 109 documents, with an h-index of 14. Dr. Prajapati has authored 52 documents in the field of pharmaceutical sciences. For further information, including metrics and setting alerts, please visit the full profile on Scopus

Education:

Dr. Prajapati holds a Ph.D. in Quality Assurance from Maliba Pharmacy College, VNSGU, Surat. He furthered his academic journey with a PGDBA from IGNOU, Surat, after completing his Master’s and Bachelor’s degrees in Pharmacy from prestigious institutions in Gujarat.

Research Focus:

Dr. Prajapati’s research interests center around pharmaceutical analysis, with a particular emphasis on quality assurance and quality control. His work spans stability studies of pharmaceutical formulations, analytical method development and validation, degradation kinetics of drugs, and the application of novel techniques like carbon nanodots and graphene quantum dots.

Professional Journey:

With over 16 years of teaching experience, Dr. Prajapati has served as an Assistant Professor and currently holds the position of Associate Professor at Maliba Pharmacy College. He has mentored numerous postgraduate and undergraduate students and is recognized as a supervisor for PG and PhD programs at Uka Tarsadia University. His expertise in analytical instruments and software has enabled him to conduct advanced research in pharmaceutical analysis.

Honors & Awards:

Dr. Prajapati’s contributions have been acknowledged through various awards and honors. Notably, he has received the Dr. P D Sethi Memorial National Award for his outstanding research papers, along with nominations for prestigious awards like the ‘Bharat Shiksha Ratan Award’. His excellence in pharmaceutical science has been recognized through multiple accolades.

Publications Top Noted & Contributions:

Dr. Prajapati has a prolific publication record, with over 75 research papers published in esteemed international and national journals. His research contributions, particularly those indexed in Scopus and Web of Science, reflect the impact and significance of his work in the field of pharmaceutical analysis and quality assurance.

Title: Principal Component Analysis and DoE-Based AQbD Approach to Multipurpose HPTLC Method for Synchronous Estimation of Multiple FDCs of Metformin HCl, Repaglinide, Glibenclamide and Pioglitazone HCl

  • Journal: Journal of Chromatographic Science
  • Date: February 2, 2024
  • DOI: 10.1093/chromsci/bmac055
  • Contributors: Pintu Prajapati; Khushbu Radadiya; Shailesh Shah
  • This article likely discusses the application of Principal Component Analysis (PCA) and Design of Experiments (DoE)-Based Analytical Quality by Design (AQbD) approach to develop a High-Performance Thin-Layer Chromatography (HPTLC) method for estimating multiple Fixed Dose Combinations (FDCs) of pharmaceutical compounds including Metformin HCl, Repaglinide, Glibenclamide, and Pioglitazone HCl.

Title: Simultaneous Chromatographic Estimation of Vildagliptin and Dapagliflozin Using Hybrid Principles of White Analytical Chemistry and Analytical Quality by Design

  • Journal: Journal of AOAC International
  • Date: January 4, 2024
  • DOI: 10.1093/jaoacint/qsad108
  • Contributors: Pintu Prajapati; Bageshree Rana; Veera Shakar Pulusu; Shailesh Shah
  • This article likely presents a chromatographic method for the simultaneous estimation of Vildagliptin and Dapagliflozin utilizing a hybrid approach combining principles of White Analytical Chemistry and Analytical Quality by Design (AQbD).

Title: Robust method operable design region for economical and eco‐friendly chromatographic analysis of azilsartan medoxomil and cilnidipine by incorporating a hybrid approach of green analytical chemistry and analytical quality by design

  • Journal: SEPARATION SCIENCE PLUS
  • Date: November 2023
  • DOI: 10.1002/sscp.202300111
  • Contributors: Pintu Prajapati; Abhinandan Shahi; Aneri Acharya; Veerashakar Pulusu; Shailesh Shah
  • This article probably discusses the development of a robust and eco-friendly chromatographic analysis method for azilsartan medoxomil and cilnidipine, incorporating a hybrid approach of green analytical chemistry and AQbD.

Title: Principles of White Analytical Chemistry and Design of Experiments to Development of Stability-Indicating Chromatographic Method for the Simultaneous Estimation of Thiocolchicoside and Lornoxicam

  • Journal: Journal of AOAC International
  • Date: November 2, 2023
  • DOI: 10.1093/jaoacint/qsad082
  • Contributors: Pintu Prajapati; Veera Shakar Pulusu; Shailesh Shah
  • This article may describe the application of White Analytical Chemistry principles and Design of Experiments (DoE) for developing a stability-indicating chromatographic method for estimating Thiocolchicoside and Lornoxicam simultaneously.

Title: Green analytical chemistry‐driven response surface modeling to stability‐indicating chromatographic method for estimation of cilnidipine and application of high‐performance thin‐layer chromatography–mass spectrometry for characterization of degradation products

  • Journal: Journal of Separation Science
  • Date: October 2023
  • DOI: 10.1002/jssc.202300332
  • Contributors: Pintu Prajapati; Varsha Dixit; Veera Shakar Pulusu; Renu Chauhan; Shailesh Shah
  • This article probably discusses the use of green analytical chemistry principles for developing a stability-indicating chromatographic method for estimating cilnidipine. Additionally, it may cover the application of high-performance thin-layer chromatography–mass spectrometry for characterizing degradation products..

Research Timeline:

Dr. Prajapati’s research journey spans over 14 years, during which he has demonstrated a consistent commitment to advancing pharmaceutical analysis and quality assurance. From his early academic pursuits to his current position as a respected researcher and educator, his timeline highlights a progression marked by notable achievements and contributions to the field.